11 clinical sites have joined the study of the Russian drug against COVID-19

(BIOCAD) On May 12, 2020, the Ministry of Health of the Russian Federation approved clinical trials of a Russian drug with the INN levilimab at 11 healthcare centers. Doctors note the improvement of condition of patients with confirmed moderate coronavirus. The drug authorization by the Ministry of Health of the Russian Federation is expected at the end of May 2020.